CD79A and COVID-19: Regarding SARS CoV-2, in their preprint article Huan et al. (2020) revealed that both IgM and IgA had early responses, while IgG showed up later, so they suggest IgA should be included in a serological test, which may provide higher diagnostic accuracy for COVID-19.